Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Feb 21, 2010; 16(7): 862-867
Published online Feb 21, 2010. doi: 10.3748/wjg.v16.i7.862
Table 1 Characteristics of the patients n (%)
Group I (n = 1119)Group II (n = 871)P value
Age mean (SD)66.7 (12.4)69.1 (11.5)0.000
Sex0.027
Males638 (57)531 (61)
Females481 (43)340 (39)
Tumor localization
Distal to splenic flexure831 (75)644 (74)
Proximal to splenic flexure272 (25)227 (26)
TNM0.11
I190 (17)122 (14)
II403 (36)348 (40)
III302 (27)244 (28)
IV224 (20)157 (18)
Tumor differentiation0.000
Poor45 (4)70 (8)
Well-moderate 1074 (96)801 (92)
Receiving chemotherapy190 (17)409 (46.9)0.000
Table 2 Mortality variation in relation to 4 independent risk factors
Hazard ratio (95% CI)
Stage
II vs I1.6 (1.2–2.1)
III vs I3.5 (2.7–4.6)
IV vs I13.7 (10.4-18.0)
Group
Ivs II2.0 (1.7–2.4)
Chemotherapy
No vs Yes1.6 (1.3–1.9)
Grade
I, II vs III1.5 (1.1–1.9)
Table 3 Comparison of age, rectal localization, post-surgery mortality and administration of chemo and/or radiotherapy n (%)
Stage I
Stage II
Stage III
Stage IV
Group I (n = 190)Group II (n = 122)Group I (n = 403)Group II (n = 348)Group I (n = 302)Group II (n = 244)Group I (n = 224)Group II (n = 157)
Age66.77066.77066.77067.570
Rectal localization93 (49)65 (44)121 (30)115 (33)103 (34)81 (33)67 (30)49 (31)
Postoperative mortality17 (9)2 (2)20 (5)7 (2)21 (7)5 (2)29 (13)6 (4)
Chemotherapy and/or radiotherapy10 (5)10 (8)48 (12)90 (26)91 (30)137 (56)54 (24)55 (35)